Evidence map›Paper›PMID 33361608›Full record

ArticleJournal of Parkinson's disease2021

Slow Wave Sleep and EEG Delta Spectral Power are Associated with Cognitive Function in Parkinson's Disease.

Kimberly H Wood, Adeel A Memon, Raima A Memon, Allen Joop, Jennifer Pilkington, Corina Catiul, Adam Gerstenecker, Kristen Triebel, Gary Cutter, Marcas M Bamman and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of Parkinson's disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Refining the Parkinson's Disease Risk Estimator for Decline In Cognition Tool (PREDICT).Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Impaired glymphatic function assessed by DTI-ALPS in drug-naïve Parkinson's disease and its association with motor and non-motor symptoms.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kimberly H WoodDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Adeel A MemonDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Raima A MemonDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA.
Allen JoopDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Jennifer PilkingtonDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Corina CatiulDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Adam GersteneckerDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Kristen TriebelDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
Gary CutterDepartment of Biostatistics, University of Alabama at Birmingham, Birmingham, AL, USA.
Marcas M BammanDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL, USA.
Svjetlana MiocinovicDepartment of Neurology, Emory University, Atlanta, GA, USA.
Amy W AmaraDepartment of Neurology, University of Alabama at Birmingham, Birmingham, AL, USA.
University of Alabama at Birmingham · USEmory University · USSamford University · US

Funding

National Dissemination of I-Corps@NCATS: Accelerating Translation through CommercializationUL1TR003096 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUTIERREZ, ORLANDO M, KIMBERLY, ROBERT P. · 2019 to 2023
$43.6M
UAB Center for Clinical and Translational Science (CCTS) UL1UL1TR000165 · NCATS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KIMBERLY, ROBERT P. · 2012 to 2013
$9.6M
Rehabilitation Research Resource to Enhance Clinical Trials (ReACT)P2CHD086851 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BAMMAN, MARCAS M · 2015 to 2019
$7.1M
Interdisciplinary Training in Pathobiology and Rehabilitation Medicine.T32HD071866 · NICHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JAMES RIMMER, Anna E. Thalacker-Mercer · 2012 to 2026
$4.8M
The essentiality of serine and glycine for skeletal muscle regeneration in agingR01AG075059 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI THALACKER-MERCER, ANNA E. · 2022 to 2025
$1.5M
UAB Research Education Program for Residents and Fellows in NeuroscienceR25NS079188 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STANDAERT, DAVID G. · 2012 to 2022
$1.1M
The Effect of Low Frequency STN DBS on Sleep and Vigilance in PD PatientsK23NS080912 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMARA, AMY WILLIS · 2012 to 2016
$934k
NCATS NIH HHS UL1 TR000165NCATS NIH HHS UL1 TR003096NIA NIH HHS R01 AG075059NICHD NIH HHS P2C HD086851NICHD NIH HHS T32 HD071866NINDS NIH HHS K23 NS080912NINDS NIH HHS R25 NS079188
6 · The paper itself

Abstract

backgroundCognitive and sleep dysfunction are common non-motor symptoms in Parkinson's disease (PD).

objectiveDetermine the relationship between slow wave sleep (SWS) and cognitive performance in PD.

methodsThirty-two PD participants were evaluated with polysomnography and a comprehensive level II neurocognitive battery, as defined by the Movement Disorders Society Task Force for diagnosis of PD-mild cognitive impairment. Raw scores for each test were transformed into z-scores using normative data. Z-scores were averaged to obtain domain scores, and domain scores were averaged to determine the Composite Cognitive Score (CCS), the primary outcome. Participants were grouped by percent of SWS into High SWS and Low SWS groups and compared on CCS and other outcomes using 2-sided t-tests or Mann-Whitney U. Correlations of cognitive outcomes with sleep architecture and EEG spectral power were performed.

resultsParticipants in the High SWS group demonstrated better global cognitive function (CCS) (p = 0.01, effect size: r = 0.45). In exploratory analyses, the High SWS group showed better performance in domains of executive function (effect size: Cohen's d = 1.05), language (d = 0.95), and processing speed (d = 1.12). Percentage of SWS was correlated with global cognition and executive function, language, and processing speed. Frontal EEG delta power during N3 was correlated with the CCS and executive function. Cognition was not correlated with subjective sleep quality.

conclusionIncreased SWS and higher delta spectral power are associated with better cognitive performance in PD. This demonstrates the significant relationship between sleep and cognitive function and suggests that interventions to improve sleep might improve cognition in individuals with PD.

Indexed as

Parkinson DiseaseSleep, Slow-WaveCognitionElectroencephalographyHumansSleepSleep QualitycognitionParkinson’s diseasesleepslow wave sleep

Identifiers

PMID33361608
PMCPMC8058231
OpenAlexW3115358267

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.